Submillimetric Beams Research Articles

The JCMT Transient Survey: Six Year Summary of 450/850 μm Protostellar Variability and Calibration Pipeline Version 2.0

The James Clerk Maxwell Telescope (JCMT) Transient Survey has been monitoring eight Gould Belt low-mass star-forming regions since 2015 December and six somewhat more distant intermediate-mass star-forming regions since 2020 February with the Submillimeter Common User Bolometer Array 2 on board JCMT at 450 and 850 μm and with an approximately monthly cadence. We introduce our pipeline v2 relative calibration procedures for image alignment and flux calibration across epochs, improving on our previous pipeline v1 by decreasing measurement uncertainties and providing additional robustness. These new techniques work at both 850 and 450 μm, where version 1 only allowed investigation of the 850 μm data. Pipeline v2 achieves better than 0.″5 relative image alignment, less than a tenth of the submillimeter beam widths. The version 2 relative flux calibration is found to be 1% at 850 μm and <5% at 450 μm. The improvement in the calibration is demonstrated by comparing the two pipelines over the first 4 yr of the survey and recovering additional robust variables with version 2. Using the full 6 yr of the Gould Belt survey, the number of robust variables increases by 50%, and at 450 μm we identify four robust variables, all of which are also robust at 850 μm. The multiwavelength light curves for these sources are investigated and found to be consistent with the variability being due to dust heating within the envelope in response to accretion luminosity changes from the central source.

Immune-Mediated Effects of Microplanar Radiotherapy with a Small Animal Irradiator.

Simple SummaryHalf of all cancer patients receive radiation therapy during their course of treatment. The destructive effects of radiation on normal tissue causes side effects that significantly affect the patient’s quality of life. Microplanar radiation therapy (MRT) is a novel, promising method that, in animal models, has shown fewer effects on normal tissue and better therapeutic efficacy. MRT does not expose the entire tissue to intense radiation, but has micron-scale “valleys” between the peaks of radiation. We have previously developed an accessible method to apply MRT. Using our approach, here, we show that MRT greatly enhanced the response of the immune system to the tumor by stimulating specific signaling molecules. Moreover, we show that combining MRT with immune checkpoint therapy was even more effective in reducing the treated tumors, possibly pointing towards using similar approaches in the clinic.Spatially fractionated radiotherapy has been shown to have effects on the immune system that differ from conventional radiotherapy (CRT). We compared several aspects of the immune response to CRT relative to a model of spatially fractionated radiotherapy (RT), termed microplanar radiotherapy (MRT). MRT delivers hundreds of grays of radiation in submillimeter beams (peak), separated by non-radiated volumes (valley). We have developed a preclinical method to apply MRT by a commercial small animal irradiator. Using a B16-F10 murine melanoma model, we first evaluated the in vitro and in vivo effect of MRT, which demonstrated significant treatment superiority relative to CRT. Interestingly, we observed insignificant treatment responses when MRT was applied to Rag−/− and CD8-depleted mice. An immuno-histological analysis showed that MRT recruited cytotoxic lymphocytes (CD8), while suppressing the number of regulatory T cells (Tregs). Using RT-qPCR, we observed that, compared to CRT, MRT, up to the dose that we applied, significantly increased and did not saturate CXCL9 expression, a cytokine that plays a crucial role in the attraction of activated T cells. Finally, MRT combined with anti-CTLA-4 ablated the tumor in half of the cases, and induced prolonged systemic antitumor immunity.

Nuclear Fragmentation Imaging for Carbon-Ion Radiation Therapy Monitoring: an In Silico Study.

PurposeThis article presents an in vivo imaging technique based on nuclear fragmentation of carbon ions in irradiated tissues for potential real-time monitoring of carbon-ion radiation therapy (CIRT) treatment delivery and quality assurance purposes in clinical settings.Materials and MethodsA proof-of-concept imaging and monitoring system (IMS) was devised to implement the technique. Monte Carlo simulations were performed for a prospective pencil-beam scanning CIRT nozzle. The development IMS benchmark considered a 5×5-cm2 pixelated charged-particle detector stack positioned downstream from a target phantom and list-mode data acquisition. The abundance and production origins, that is, vertices, of the detected fragments were studied. Fragment trajectories were approximated by straight lines and a beam back-projection algorithm was built to reconstruct the vertices. The spatial distribution of the vertices was then used to determine plan relevant markers.ResultsThe IMS technique was applied for a simulated CIRT case, a primary brain tumor. Four treatment plan monitoring markers were conclusively recovered: a depth dose distribution correlated profile, ion beam range, treatment target boundaries, and the beam spot position. Promising millimeter-scale (3-mm, ≤10% uncertainty) beam range and submillimeter (≤0.6-mm precision for shifts <3 cm) beam spot position verification accuracies were obtained for typical therapeutic energies between 150 and 290 MeV/u.ConclusionsThis work demonstrated a viable online monitoring technique for CIRT treatment delivery. The method's strong advantage is that it requires few signal inputs (position and timing), which can be simultaneously acquired with readily available technology. Future investigations will probe the technique's applicability to motion-sensitive organ sites and patient tissue heterogeneities. In-beam measurements with candidate detector-acquisition systems are ultimately essential to validate the IMS benchmark performance and subsequent deployment in the clinic.

Monte Carlo Comparison of Proton and Helium-ion Minibeam Generation Techniques

Proton minibeam radiation therapy (pMBRT) is a novel therapeutic strategy that combines the normal tissue sparing of submillimetric, spatially fractionated beams with the improved dose deposition of protons. In contrast to conventional approaches which work with comparatively large beam diameters (5 mm to several centimetres) producing laterally homogeneous fields, pMBRT uses submillimetric minibeams to create a distinct spatial modulation of the dose featuring alternating regions of high dose (peaks) and low dose (valleys). This spatial fractionation can increase the tolerance of normal tissue and may allow a safe dose escalation in the tumour. Important quantities in this context are the valley dose as well as the peak-to-valley dose ratio (PVDR). Creating submillimetric proton beams for clinical applications is a challenging task that until now has been realized with mechanical collimators (metal blocks with thin slits or holes). However, this method is inherently inefficient, inflexible and creates undesirable secondary neutrons. We therefore recently proposed a method for obtaining clinical minibeams using only magnetic focusing. In this study, we performed Monte Carlo simulations in order to compare minibeams generated using the new method of magnetic focusing with two techniques involving mechanical collimators (collimator and broad beam irradiation, collimator and pencil beam scanning). The dose deposition in water was simulated and dosimetric aspects [beam broadening, depth-dose profiles, PVDR and Bragg-peak-to-entrance dose ratio (BEDR)] as well as irradiation efficiencies were evaluated. Apart from protons, we also considered helium ions which, due to their reduced lateral scattering and sharper Bragg peak, may present a promising alternative for minibeam radiation therapy. Magnetically focused minibeams exhibited a 20–60 times higher PVDR than mechanically collimated minibeams and yielded an increase in irradiation efficiency of up to two orders of magnitude. Compared to proton minibeams, helium ion minibeams were found to broaden at a slower rate and yield an even higher PVDR (at the same minibeam spacing) as well as a more favourable BEDR. Moreover, the simulations showed that methods developed for proton minibeams are suitable for the generation of helium ion minibeams.

Optimizing proton minibeam radiotherapy by interlacing and heterogeneous tumor dose on the basis of calculated clonogenic cell survival

Proton minibeam radiotherapy (pMBRT) is a spatial fractionation method using sub-millimeter beams at center-to-center (ctc) distances of a few millimeters to widen the therapeutic index by reduction of side effects in normal tissues. Interlaced minibeams from two opposing or four orthogonal directions are calculated to minimize side effects. In particular, heterogeneous dose distributions applied to the tumor are investigated to evaluate optimized sparing capabilities of normal tissues at the close tumor surrounding. A 5 cm thick tumor is considered at 10 cm depth within a 25 cm thick water phantom. Pencil and planar minibeams are interlaced from two (opposing) directions as well as planar beams from four directions. An initial beam size of σ0 = 0.2 mm (standard deviation) is assumed in all cases. Tissue sparing potential is evaluated by calculating mean clonogenic cell survival using a linear-quadratic model on the calculated dose distributions. Interlacing proton minibeams for homogeneous irradiation of the tumor has only minor benefits for the mean clonogenic cell survival compared to unidirectional minibeam irradiation modes. Enhanced mean cell survival, however, is obtained when a heterogeneous dose distribution within the tumor is permitted. The benefits hold true even for an elevated mean tumor dose, which is necessary to avoid cold spots within the tumor in concerns of a prescribed dose. The heterogeneous irradiation of the tumor allows for larger ctc distances. Thus, a high mean cell survival of up to 47% is maintained even close to the tumor edges for single fraction doses in the tumor of at least 10 Gy. Similar benefits would result for heavy ion minibeams with the advantage of smaller minibeams in deep tissue potentially offering even increased tissue sparing. The enhanced mean clonogenic cell survival through large ctc distances for interlaced pMBRT with heterogeneous tumor dose distribution results in optimum tissue sparing potential. The calculations show the largest enhancement of the mean cell survival in normal tissue for high-dose fractions. Thus, hypo-fractionation or even single dose fractions become possible for tumor irradiation. A widened therapeutic index at big cost reductions is offered by interlaced proton or heavy ion minibeam therapy.

X-rays minibeam radiation therapy at a conventional irradiator: Pilot evaluation in F98-glioma bearing rats and dose calculations in a human phantom

Minibeam radiation therapy (MBRT) is a type of spatial fractionated radiotherapy that uses submillimetric beams. This work reports on a pilot study on normal tissue response and the increase of the lifespan of glioma-bearing rats when irradiated with a tabletop x-ray system. Our results show a significant widening of the therapeutic window for brain tumours treated with MBRT: an important proportion of long-term survivals (60%) coupled with a significant reduction of toxicity when compared with conventional (broad beam) irradiations. In addition, the clinical translation of the minibeam treatment at a conventional irradiator is evaluated through a possible human head treatment plan.

Optimization of hexagonal-pattern minibeams for spatially fractionated radiotherapy using proton beam scanning.

In this study, we investigated computationally and experimentally a hexagonal-pattern array of spatially fractionated proton minibeams produced by proton pencil beam scanning (PBS) technique. Spatial fractionation of dose delivery with millimeter or submillimeter beam size has proven to be a promising approach to significantly increase the normal tissue tolerance. Our goals are to obtain an optimized minibeam design and to show that it is feasible to implement the optimized minibeams at the existing proton clinics. An optimized minibeam arrangement is one that would produce high peak-to-valley dose ratios (PVDRs) in normal tissues and a PVDR approaching unity at the Bragg peak. Using Monte Carlo (MC) code TOPAS we simulated proton pencil beams that mimic those available at the existing proton therapy facilities and obtained a hexagonal-pattern array of minibeams by collimating the proton pencil beams through the 1-3mm diameter pinholes of a collimator. We optimized the minibeam design by considering different combinations of parameters including collimator material and thickness (t), center-to-center (c-t-c) distance, and beam size. The optimized minibeam design was then evaluated for normal tissue sparing against the uniform pencil beam scanning (PBS) by calculating the therapeutic advantage (TA) in terms of cell survival fraction. Verification measurements using radiochromic films were performed at the Emory proton therapy center (EPTC). Optimized hexagonal-pattern minibeams having PVDRs of >10 at phantom surface and of >3 at depths up to 6cm were achieved with 2mm diameter modulated proton minibeams (with proton energies between 120 and 140MeV) corresponding to a spread-out-Bragg-peak (SOBP) over the depth of 10-14cm. The results of the film measurements agree with the MC results within 10%. The TA of the 2mm minibeams against the uniform PBS is >3 from phantom surface to the depth of 5cm and then smoothly drops to ~1.5 as it approaches the proximal edge of the SOBP. For 2mm minibeams and 6mm c-t-c distance, we delivered 1.72Gy at SOBP for 7.2×7.2×4cm3 volume in 48s. We conclude that it is feasible to implement the optimized hexagonal-pattern 2mm proton minibeam radiotherapy at the existing proton clinics, because desirable PVDRs and TAs are achievable and the treatment time is reasonable.

Beam size limit for pencil minibeam radiotherapy determined from side effects in an in-vivo mouse ear model.

Side effects caused by radiation are a limiting factor to the amount of dose that can be applied to a tumor volume. A novel method to reduce side effects in radiotherapy is the use of spatial fractionation, in which a pattern of sub-millimeter beams (minibeams) is applied to spare healthy tissue. In order to determine the skin reactions in dependence of single beam sizes, which are relevant for spatially fractionated radiotherapy approaches, single pencil beams of submillimeter to 6 millimeter size were applied in BALB/c mice ears at a Small Animal Radiation Research Platform (SARRP) with a plateau dose of 60 Gy. Radiation toxicities in the ears were observed for 25 days after irradiation. Severe radiation responses were found for beams ≥ 3 mm diameter. The larger the beam diameter the stronger the observed reactions. No ear swelling and barely reddening or desquamation were found for the smallest beam sizes (0.5 and 1 mm). The findings were confirmed by histological sections. Submillimeter beams are preferred in minibeam therapy to obtain optimized tissue sparing. The gradual increase of radiation toxicity with beam size shows that also larger beams are capable of healthy tissue sparing in spatial fractionation.

Improvements and reproducibility of an optimal grazing-incidence position method to L-shell x-ray fluorescence measurements of lead in bone and soft tissue phantoms

L-shell x-ray fluorescence (LXRF) is a non-invasive approach to lead (Pb) concentration measurements in human bone. The method is based on the detection of the characteristic x-ray photons of Pb at 10.5 and 12.6 keV and experimental studies were designed to perform in vivo human bone Pb measurements. In later studies, however, the initial LXRF methodology was shown to have poor accuracy and precision. In a recent publication, we investigated an optimal grazing-incidence position (OGIP) approach using a sub-millimeter x-ray beam from an integrated x-ray tube and polycapillary x-ray lens table-top system. The OGIP method effectively reduced the x-ray scatter and produced a Pb detection limit of ∼5 μg/g for a 2 mm soft tissue phantom thickness. In this study, the OGIP methodology was improved by using 10 s x-ray spectra acquisitions at sequential positions 0.5 mm apart. The measured Sr Kα peak height versus position data was used to spectroscopically identify the bone phantom and the OGIP. The data was fitted with the analytical convolution between a Gaussian and an exponential decay. The position corresponding to the maximum of the fitted convolution function was then selected as the OGIP. Four phantom sets were used. A cylindrical plaster-of-Paris bone phantom doped with Pb in a concentration of 74 μg/g was used as a bare bone phantom or with one of the three overlying polyoxymethylene cylindrical shell soft tissue phantoms of 1, 2, and 3 mm thickness. The reproducibility of the OGIP method was assessed in five independent trials using each of the four phantom sets. The coefficient of variation (COV) percentage values of the Sr Kα peak height measurements were below 5%. The new procedure decreased by more than threefold the duration and radiation dose of the earlier approach.

A flexible terahertz waveguide for delivery and filtering of quantum-cascade laser radiation

We demonstrate that a specially designed microstructured polymer waveguide can improve the quality of quantum cascade laser radiation. It can filter out undesired side frequencies and transform the delivered radiation to a sub-millimeter size beam with a Gaussian-like cross-section. The spatial distribution of the bended waveguide mode is measured, and low bending losses of the fundamental mode are confirmed. Detailed optimization of a capillary structure for 3 THz frequency allows delivering single frequency radiation up to a 1 meter distance. The results of the experimental study are confirmed by calculations with an accurate mode solver that explains the achieved losses of ∼10 dB/m. A further improvement strategy is suggested.

Quantitative evaluation of potential irradiation geometries for carbon-ion beam grid therapy.

Radiotherapy using grids containing cm-wide beam elements has been carried out sporadically for more than a century. During the past two decades, preclinical research on radiotherapy with grids containing small beam elements, 25 μm-0.7 mm wide, has been performed. Grid therapy with larger beam elements is technically easier to implement, but the normal tissue tolerance to the treatment is decreasing. In this work, a new approach in grid therapy, based on irradiations with grids containing narrow carbon-ion beam elements was evaluated dosimetrically. The aim formulated for the suggested treatment was to obtain a uniform target dose combined with well-defined grids in the irradiated normal tissue. The gain, obtained by crossfiring the carbon-ion beam grids over a simulated target volume, was quantitatively evaluated. The dose distributions produced by narrow rectangular carbon-ion beams in a water phantom were simulated with the PHITS Monte Carlo code. The beam-element height was set to 2.0 cm in the simulations, while the widths varied from 0.5 to 10.0 mm. A spread-out Bragg peak (SOBP) was then created for each beam element in the grid, to cover the target volume with dose in the depth direction. The dose distributions produced by the beam-grid irradiations were thereafter constructed by adding the dose profiles simulated for single beam elements. The variation of the valley-to-peak dose ratio (VPDR) with depth in water was thereafter evaluated. The separation of the beam elements inside the grids were determined for different irradiation geometries with a selection criterion. The simulated carbon-ion beams remained narrow down to the depths of the Bragg peaks. With the formulated selection criterion, a beam-element separation which was close to the beam-element width was found optimal for grids containing 3.0-mm-wide beam elements, while a separation which was considerably larger than the beam-element width was found advantageous for grids containing 0.5-mm-wide beam elements. With the single-grid irradiation setup, the VPDRs were close to 1.0 already at a distance of several cm from the target. The valley doses given to the normal tissue at 0.5 cm distance from the target volume could be limited to less than 10% of the mean target dose if a crossfiring setup with four interlaced grids was used. The dose distributions produced by grids containing 0.5- and 3.0-mm wide beam elements had characteristics which could be useful for grid therapy. Grids containing mm-wide carbon-ion beam elements could be advantageous due to the technical ease with which these beams can be produced and delivered, despite the reduced threshold doses observed for early and late responding normal tissue for beams of millimeter width, compared to submillimetric beams. The treatment simulations showed that nearly homogeneous dose distributions could be created inside the target volumes, combined with low valley doses in the normal tissue located close to the target volume, if the carbon-ion beam grids were crossfired in an interlaced manner with optimally selected beam-element separations. The formulated selection criterion was found useful for the quantitative evaluation of the dose distributions produced by the different irradiation setups.

MPISI: The neutron strain scanner materials probe for internal strain investigations at the SAFARI-1 research reactor

A modern neutron strain scanner instrument with crystallographic texture measurement capability has been established at the SAFARI-1 research reactor. This instrument, MPISI, has been benchmarked against the VAMAS Ring-and-Plug specimen, as well as in high spatial resolution mode using sub-millimeter beams. It is equipped with a double focused Si-multiwafer monochromator, sturdy high-precision sample manipulation stages, adjustable primary and secondary beam apertures interchangeable with radial collimators (RCs) on the secondary beam side and a 300 × 300 mm2 position sensitive neutron area detector. The RCs facilitate measurement of large specimens and interfaces. Variation in monochromator horizontal curvature allows optimization of the intensity (texture), resolution (peak broadening), or Figure-of-Merit (strain) with an achievable resolution of Δd/d ∼ 3 × 10−3. An Android based Wi-Fi hand-held control module in conjunction with lasers and theodolites aid with sample positioning and alignment. Data acquisition and control has been standardised on the SINQ Instrument Control Software. In-house developed data reduction software enables: flat field correction, geometric correction, vertical integration, data normalization, peak and entry-curve fitting, as well as multi-dimensional data visualization. Acquiring data against statistical criteria rather than time improves the overall instrument utilisation efficiency.

Optimization of beam arrangements in proton minibeam radiotherapy by cell survival simulations.

Proton minibeam radiotherapy using submillimeter beam dimensions allows to enhance tissue sparing in the entrance channel by spatial fractionation additionally to advantageous proton depth dose distribution. In the entrance channel, spatial fractionation leads to reduced side effects compared to conventional proton therapy. The submillimeter sized beams widen with depth due to small angle scattering and enable therefore, in contrary to x-ray microbeam radiation therapy (MRT), the homogeneous irradiation of a tumor. Proton minibeams can either be applied as planar minibeams or pencil shaped with an additional possibility to vary between a quadratic and a hexagonal arrangement for pencil minibeams. The purpose of this work is to deduce interbeam distances to achieve a homogeneous dose distribution for different tumor depths and tumor thicknesses. Furthermore, we aim for a better understanding of the sparing effect on the basis of surviving cells calculated by the linear-quadratic model. Two-dimensional dose distributions are calculated for proton minibeams of different shapes and arrangements. For a tumor in 10-15cm depth, treatment plans are calculated with initial beam size of σ0 =0.2mm in a water phantom. Proton minibeam depth dose distributions are finally converted into cell survival using a linear-quadratic model. Inter proton beam distances are maximized under the constraint of dose homogeneity in the tumor for tumor depths ranging from 4 to 15cm and thickness ranging from 0.5 to 10cm. Cell survival calculations for a 5cm thick tumor covered by 10cm healthy tissue show less cell death by up to 85%, especially in the superficial layers, while keeping the cell death in the tumor as in conventional therapy. In the entrance channel, the pencil minibeams result in higher cell survival in comparison to the planar minibeams while all proton minibeam irradiations show higher cell survival than conventional broadbeam irradiation. The deduced constraints for interbeam distances simplify treatment planning for proton minibeam radiotherapy applications in future studies. The cell survival results indicate that proton minibeam radiotherapy reduces side effects but keeps tumor control as in conventional proton therapy. It makes proton minibeam, especially pencil minibeam radiotherapy a potentially attractive new approach for radiation therapy.

Electron beam focusing features in a plasma electron source under forevacuum pressures

Features of focusing electron beams generated by a forevacuum plasma source under pressures of 10–30 Pa are investigated and the principle possibility of obtaining submillimeter beams is demonstrated. A beam power density of 105 W/cm2 is reached at an electron beam diameter of 0.6 mm. The obtained beam parameters offer opportunities for precision electron beam processing of dielectric materials, including hightemperature alumina ceramics.

Large areas elemental mapping by ion beam analysis techniques

The external beam line of the Laboratory for Material Analysis with Ion Beams (LAMFI) is a versatile setup for multi-technique analysis. X-ray detectors for Particle Induced X-rays Emission (PIXE) measurements, a Gamma-ray detector for Particle Induced Gamma- ray Emission (PIGE), and a particle detector for scattering analysis, such as Rutherford Backscattering Spectrometry (RBS), were already installed. In this work, we present some results, using a large (60-cm range) XYZ computer controlled sample positioning system, completely developed and build in our laboratory. The XYZ stage was installed at the external beam line and its high spacial resolution (better than 5 μm over the full range) enables positioning the sample with high accuracy and high reproducibility. The combination of a sub-millimeter beam with the large range XYZ robotic stage is being used to produce elemental maps of large areas in samples like paintings, ceramics, stones, fossils, and all sort of samples. Due to its particular characteristics, this is a unique device in the sense of multi-technique analysis of large areas. With the continuous development of the external beam line at LAMFI, coupled to the robotic XYZ stage, it is becoming a robust and reliable option for regular analysis of trace elements (Z > 5) competing with the traditional in-vacuum ion-beam-analysis with the advantage of automatic rastering.

Video-EEG Analysis Following Microradiosurgical Transections of Rat Sensorimotor Cortex Seizure Focus

Introduction: Multiple subpial transections are an alternative to resection of the epileptic focus for select patients. Microradiosurgery is a developing technique, which uses submillimetric beams of radiation to treat disease. This preliminary study was designed to evaluate electroencephalography and behavioral findings following microradiosurgical transcortical transection (MTT) of a rat seizure focus. Materials and Methods: Kainic acid was used to induce a seizure focus within the left sensorimotor cortex of two rats. Before and up to 10 hours following synchrotron-generated MTT, video-EEG was recorded.

Synchrotron-generated microbeam radiosurgery: a novel experimental approach to modulate brain function

<title/>Synchrotron-generated X-ray microplanar beams (microbeams) are characterized by peculiar biological properties such as a remarkable tissue-sparing effect in healthy tissues including the central nervous system (CNS) and, as a direct consequence, the ability to deliver extremely high doses without induction of radionecrosis. Growing experimental evidence is showing remarkable tolerance of brain and spinal cord to irradiation with microbeam arrays delivering doses up to 400 Gy with a beam width up to 0·7 mm. Submillimetric beams can be delivered following a stereotactic design bringing to the target doses in the range of hundreds of Gray without harm to the surrounding tissues. Microbeam arrays can be used to generate cortical transections or subcortical lesions, thus enabling the non-invasive modulation of brain networks. This novel microradiosurgical approach is of great interest for the treatment of a variety of brain disorders, including functional diseases such as epilepsy and movement disorders.

Microbeam radiosurgery using synchrotron-generated submillimetric beams: a new tool for the treatment of brain disorders

Since its advent during the mid-twentieth century, radiosurgery has undergone a steady evolution. Gamma Knife and linear accelerator based systems using rigid frames preceded the development of frameless devices. The present report describes the development of microbeam radiosurgery, a technique which uses submillimetric beams of radiation to treat disease. Typically, the technique is employed using parallel arrays of beams delivered via a high-fluence synchrotron source. Beam widths between 20 and 950 μm have been used with the majority of studies utilizing beam widths less than 100 μm. In addition to its high precision, the technique allows users to take advantage of two unique properties of microbeams. The first is a remarkable tolerance of healthy tissue to microbeams delivered at doses up to several hundred grays, while at the same time, tumors are highly susceptible to the lethal effects of microbeams. Together, these findings allow for a "preferential tumoricidal effect" beyond the typical dose-volume relationship. Although only used in animal experiments so far, we explore the hypothetical clinical role of microbeam radiosurgery which may be feasible in the near future. In addition to the treatment of traditional radiosurgery targets such as malignancies and vascular malformations, microbeams may allow the non-invasive treatment of functional disease such as movement disorders, epilepsy, and mental illness.

An external sub-milliprobe optimized for PIXE analysis of archaeological samples

A simple and compact electrostatic quadrupole triplet lens has been designed and fabricated as part of the dedicated beam line for analysis of archaeological samples. A Fortran based ion optics program has been developed to simulate the beam line and lens parameters to achieve a focused sub-millimeter beam spot. The results of simulations are utilized to design and fabricate beam-line elements. The beam spot was measured by wire scanning method to be 0.3 mm for the object-slit width of 1 mm at a distance of 15 mm from the exit window. The improved Ion Beam Analysis setup allows accelerated PIXE analysis of samples whose details are comparable with the beam probe in size. The PIXE spectrum obtained by external analysis of a historical enameled ceramic sample with a sub-millimeter beam is compared with that obtained by in-vacuum standard PIXE analysis.

Performance evaluation of a CyberKnife® G4 image-guided robotic stereotactic radiosurgery system

The aim of the current work was to present the performance evaluation procedures implemented at our department for the commissioning of a G4 CyberKnife system. This system consists of a robotic manipulator, a target-locating system and a lightweight 6-MV linac. Individual quality assurance procedures were performed for each of the CyberKnife subsystems. The system was checked for the mechanical accuracy of its robotic manipulator. The performance of the target-locating system was evaluated in terms of mechanical accuracy of both cameras' alignment and quality assurance tests of the x-ray generators and the flat-panel detectors. The traditional linac 6-MV beam characteristics and beam output parameters were also measured. Results revealed a manipulator mechanical mean accuracy of ∼0.1 mm, with individual maximum position uncertainties less than 0.25 mm. The target-locating system mechanical accuracy was found within the acceptance limits. For the most clinically used parameters in the CyberKnife practice, e.g. 100–120 kV and 50–200 ms, kV and exposure time accuracy error were measured as less than 2%, while the precision error of the kV was determined as less than 1%. The acquired images of the ETR grid pattern revealed no geometrical distortion while the critical frequency f50 values for cameras A and B were calculated as 1.5 lp mm−1 and 1.4 lp mm−1, respectively. Dose placement measurements were performed in a head and neck phantom. Results revealed sub-millimeter beam delivery precision whereas the total clinical accuracy of the system was measured equal to 0.44 ± 0.12 mm, 0.29 ± 0.10 mm and 0.53 ± 0.16 mm for the skull, fiducial and Xsight spine tracking methods, respectively. The results of this work certify the G4 CyberKnife SRS system capable of delivering high dose distributions with sub-millimeter accuracy and precision to intracranial and extracranial lesions. Moreover, total clinical accuracy of the investigated G4 system was found to be improved for the skull and fiducial tracking methods and was comparable for Xsight spine tracking method compared with the earlier generation of the instrument.